11 October 2024
Ropes & Gray Advises on the Launch of Kailera Therapeutics
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Arthur Mok Lead | Ropes & Gray | Partner | corporate | New York |
| Geoffrey Lin Lead | Ropes & Gray | Partner | licensing | San Francisco |
| Ray Grant | Ropes & Gray | Counsel | corporate | Boston |
| Evan Tallmadge | Ropes & Gray | Associate | licensing | Boston |
| Katherine Wang | Ropes & Gray | Partner | regulatory | Singapore |
| Ama Adams | Ropes & Gray | Partner | national security | Washington D.C. |
| Jonathan Klarfeld | Ropes & Gray | Partner | antitrust | Washington D.C. |
| Amanda Holt | Ropes & Gray | Partner | tax | Boston |
| David Saltzman | Ropes & Gray | Partner | tax | Boston |
| Renata Ferrari | Ropes & Gray | Partner | executive compensation & employee benefits | Boston |
Stated terms
- Stated value
- USD 400m ($400 million)
- What the figure measures
- Fund size
- Client
- Kailera Therapeutics, Inc.Issuer
- Counterparties
- Atlas Venture (Investor)
Bain Capital Life Sciences (Investor)
RTW Investments (Investor)
Lyra Capital (Investor)
Hengrui Pharmaceuticals (Other)